Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Lugu Business Plaza E1, Yuelu District, 长沙市, 湖南省, CN
Canagliflozin is a medication used to treat type 2 diabetes. It is a third-line medication to be tried after metformin, a first-line medication for type 2 diabetes. It is used together with exercise and diet. It is not recommended in type 1 diabetes. Mechanism action of Canagliflozin Canagliflozin is a sodium-glucose cotransporter (SGLT2) inhibitor. Glucose filtered […]
Released By Hunan Huateng Pharmaceutical Co. Ltd
Orlistat is a drug designed to treat obesity. The main function of Orlistat is to prevent the absorption of fat from the diet in humans. It prevents the absorption of fat by acting as a lipase inhibitor, ultimately reducing calorie intake. Orlistat works by inhibiting pancreatic and gastric lipase, the enzymes of the pancreas and […]
On February 16, 2022, the data on Paxlovid previously published by Pfizer and submitted to the FDA were published in the New England Journal of Medicine (NEJM). This NEJM article published viral load data that Paxlovid reduced viral load by 0.868 log10 compared to controls for 5 days of treatment, which equates to a remarkable […]
Ensitrelvir (code name S-217622, brand name Xocova), is a new inhibitor of the SARS-CoV-2 major protease (Mpro), also known as 3C-like protease, has been shown to reduce the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters. In cells, low nanomolar to sub-micromolar doses of Ensitrelvir suppress viral growth. In hamsters, oral […]
tempContent
Rengis brings extensive international leadership experience across pharmaceutical manufacturing, R&D and CDMO operations.
By: Charlie Sternberg
The model aims to accelerate discovery and development of new Aramchol-based therapeutic approaches.
By: Patrick Lavery
The acquisition complements Bayer’s pharmaceutical pipeline and strategically fits with its footprint and expertise in ophthalmology.
There are many reasons for a pharmaceutical company to perform a tech transfer to a contract manufacturing organization (CMO).
Released By AbbVie Contract Manufacturing
To succeed in an increasingly competitive marketplace, pharmaceutical companies must have a strong Environmental, Social and Governance (ESG) strategy in place.
The new line of high-clarity PETG bottles is designed to support the demanding requirements of pharmaceutical and biopharmaceutical manufacturing environments.
The collaboration is aimed at unmet needs in treatments for corneal and ocular surface diseases.
Snellgrove brings 30+ years of financial leadership, strategic insight, and operational excellence across the biopharmaceutical and medtech sectors.
Michelle D’Angelo brings 25+ years of experience in the pharmaceutical and biotechnology CDMO sector.
Contract Pharma has launched Contract Pharma Stream, a new digital content hub designed to give pharmaceutical and biopharma professionals instant access to more than 30 live and on-demand webinars through one simple login.
By: Tim Wright
Transforms into a late-stage biopharmaceutical company with a government-backed asset and potential multiple revenue stream model.
Strengthens its leadership in low-grade glioma and expands its position in oncology.
Will establish a 185-acre pharmaceutical manufacturing campus in Durham, NC.
Will leverage Regeneron’s biologics expertise and Telix’s radiopharmaceutical development platform.
By: Kristin Brooks
The treatment was developed through a strategic partnership with Orbicular Pharmaceutical Technologies.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
